In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.
Revolution Medicines while they await what they hope will be a speedy FDA approval. The Food and Drug Administration allowed the expanded access program on May 1, less than three weeks after ...
Florida lawmakers are engaged in budget negotiations, where the House is refusing to fund several of Gov. Ron DeSantis’ priorities.
Bicara Therapeutics (NASDAQ:BCAX) said its lead cancer drug candidate, ficerafusp alfa, remains on track for pivotal data in head and neck cancer in mid-2026, as the company outlined its development ...
California officials released draft risk assessments for acrolein and ethylene oxide, two hazardous air pollutants.
Originally launched as Myeloid Therapeutics in 2021 by cell therapy pioneers Ronald Vale, Ph.D., and Siddhartha Mukherjee, ...
The main market opportunities in DLL3-targeted immunotherapies lie in the treatment of high unmet needs in small cell lung cancer and neuroendocrine carcinomas. The surge in research highlights ...
US cancer centers are grappling with an influx of patient requests for an experimental pancreatic cancer drug, daraxonrasib, ...
Ulrich Mueller, Erika Pearce recognized for their groundbreaking work on hearing loss and immune metabolism, respectively ...
Multnomah County’s homeless services department faces a nearly $70 million budget gap next fiscal year, leading to the ...
Following positive first-in-human Phase 1 single ascending dose and preliminary food-effect data with ART26.12, Artelo continues preparations to initiate the multiple ascending dose study, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results